Clinical significance of the preoperative serum-soluble intercellular adhesion molecule-1 in non-small cell lung cancer

Journal of Cardiovascular Surgery

Volumn 43, Issue 5, 2002, Pages 729-734

  Kamiyoshihara, M ^a   Kawashima, O ^b   Otani, Y ^c   Morishita, Y ^c  

^a MAEBASHI RED CROSS HOSPITAL   (Japan)

^b National Nishigunma Hospital   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Carcinoma, non small cell lung, diagnosis; Carcinoma, nonsmall cell lung, surgery; Intercellular adhesion molecule 1

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ADVANCED CANCER; AGED; AGING; ARTICLE; CANCER STAGING; CIGARETTE SMOKING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; JAPAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; METASTASIS; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS; PROTEIN BLOOD LEVEL; VENOUS BLOOD;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 0036815128     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Tomita Y, Nishiyama T, Watanabe H, Fujiwara M, Sato S. Expression of intercellular adhesion molecule-1 (ICAM-1) on renal-cell cancer: possible significance in host immune responses. Int J Cancer 1990;46:1001-6.
2. Tsujisaki M, Hirata H, Hanzawa Y, Masuya J, Nakano T, Sugiyama T et al. Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin Exp Immunol 1991;85:3-8.
3. Koyama S, Ebihara T, Fukao K. Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma. J Cancer Res Clin Oncol 1992;118:609-14.
4. Kageshita T, Yoshii A, Kimura T, Tsujisaki M. Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res 1993;53:4927-32.
5. Marlin SD, Staunton DE, Springer TA, Stratowa, C, Sommergruber W, Merluzzi VJ. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature 1990;344:70-2.
6. Seth R, Raymond FD, Makgoba MW. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 1991;338:83-4.
7. Taguchi O, Gabazza EC, Kobayashi T, Yoshida M, Yasui H, Kobayashi H. Circulating intercellular adhesion molecule-1 in patients with lung cancer. Intern Med 1997;36:14-8.
8. De Vita F, Infusino S, Auriemma A, Orditura M, Catalano G. Circulating levels of soluble intercellular adhesion molecule-1 in non-small cell lung cancer patients. Oncol Rep 1998;5:393-6.
9. Grothey A, Heistermann P, Philippou S, Voigtmann R. Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage. Br J Cancer 1998;77:801-7.
10. Seely JM, Mayo JR, Miller RR, Muler NL. T1 lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT. Radiology 1993;186:129-32.
11. McLoud TC, Bourgouin PM, Greenberg RW, Kosiuk JP, Templeton PA, Shepard Jo-Anne O et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992;182:319-23.
12. World Health Organization. Histological typing of lung tumors. Tumor 1981;67:253-72.
13. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7.
14. International Union Against Cancer (UICC). Lung tumors (ICDO-0612). In: Hermanek P, Sobin LH, editors. TNM classification of malignant tumors. Berlin: Spinger-Verlag, 1987:70-3.
15. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability of various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 1987;76:832-9.
16. Larson RS, Springer TA. Structure and function of leucocyte integrins. J Immunol Rev 1990;114:181-5.
17. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
18. Diamond MS, Staunton DE, Marlin SD, Springer TA. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 1991;65:961-71.
19. Mortarini R, Belli F, Parmiani G, Anichini A. Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL-1β, rTFN-κ, rIFN-γ, rIL4 and their combinations. Int J Cancer 1990;45:334-41.
20. Osaki T, Mitsudomi T, Yoshida Y, Oyama Y, Ohgami A, Nakanishi K et al. Increased levels of serum intercellular adhesion molecule-1 (ICAM-1) in patients with non-small cell lung cancer. Surg Oncol 1996;5:107-13.
21. Schardt C, Heymanns J, Rotsch M, Havemann K. Differential expression of the intercellular adhesion molecule-1 (ICAM-1) in lung cancer cell lines of various histological types. Eur J Cancer 1993;29A:2250-5.
22. Pizzolo G, Vinante F, Nadali G, Ricetti MM, Morosato L, Marrocella R et al. ICAM-1 tissue over expression associated with increased serum levels of its soluble form in Hodgkin's disease. Br J Haematol 1993;84:161-2.